Orka Two vs Resound Vivia 9 60S microRIE

The Orka Two is a behind-the-ear prescription hearing aid priced at $1,899, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This places it in the top 67% of the 36 prescription hearing aids we've evaluated, ranking #25 in its category. In our testing, the Orka Two shows a mixed performance profile with clear strengths and weaknesses. Music streaming stands out at 3.3/5, measuring 0.66 points above the category average—a solid result for users who prioritize phone audio quality. Own-voice comfort also performs well at 3.2/5, sitting 0.45 points above average, which may contribute to a more natural listening experience. Feedback handling is excellent at 5.0/5, among the best we've measured. However, speech-in-noise performance is a notable limitation. At 1.4/5, it falls 0.56 points below the category average—a low absolute score that may affect understanding in challenging listening environments like restaurants or group conversations. Speech in quiet fares better at 3.7/5, measuring 0.40 points above average. The Orka Two may suit users who prioritize streaming quality, own-voice comfort, and stability over speech-in-noise performance. Those frequently in noisy environments should note that competitors in this price range, such as the Rexton Reach R-Li T80 at Costco (4.58/5), deliver stronger overall scores. Budget-conscious shoppers might also consider lower-priced alternatives like the Sony CRE-C10, which scored 4.19/5 in our testing.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.